Lower protein diet associated with decreased risk for cardiovascular disease
"A prescription for Viagra should include a lifesaving wake-up call for men with ED to adopt a heart-healthy diet," says Neal Barnard, MD, FACC, president of the Physicians Committee for Responsible Medicine and author of Your Body in Balance , which explains the science behind a plant-based diet's ability to fight ED. "Erectile dysfunction is a sign of narrowed arteries throughout a man's body, including the arteries to his heart and brain, putting him at high risk for heart attack, stroke, and death."
A recent meta-analysis found that men with ED have a 59 percent higher risk of coronary heart disease or atherosclerosis, a 34 percent higher risk of stroke, and a 33 percent higher risk of dying from any cause, compared with men without symptoms of ED.
A diet rich in fruits, vegetables, grains, and legumes can help reduce heart disease and ED risk. A study published in The Lancet found that heart disease can be reversed with a plant-based diet, regular exercise, stress management, and no smoking.
The same diet changes that protect the heart can also reduce ED risk. According to a study published in the journal Urology , each additional daily serving of fruits or vegetables reduced ED risk in men with diabetes by 10 percent. Strawberries, apples, blueberries, and citrus fruits may be especially beneficial. A 2016 study found that men with the highest intakes of anthocyanins, flavones, and flavanones, phytonutrients found in these and other fruits, lowered their risk for ED by 14 percent when compared to those who consumed the least.
Research shows that even a 20 percent decrease in heart attacks or strokes as a result of screening and treatment could save $21.3 billion over 20 years. More than 1 million cases of ED would also be treated, saving $9.7 billion. Source:
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology